维药芹菜根醇提物护肝降脂作用的初步探索
|
摘要
目的:初步探索维药芹菜根醇提物对四氯化碳(CCl4)、D-氨基半乳糖(D-GaIN),扑热息痛(PAR)所致的急性肝损伤的保护作用及对高脂血症大鼠血脂的调节作用。方法:(1)选用Wistar大鼠,分别用CCl4(1ml/kg)、D-GaIN(500mg/kg)进行攻击;选用昆明小鼠,用大剂量PAR(300mg/kg)进行攻击。分别建立以上三种肝损伤模型,观察维药芹菜根醇提物对实验动物血清谷丙转氨酶(ALT)、谷草转氨酶(AST)和肝组织超氧化物歧化酶(SOD)活性、丙二醛(MDA)含量及病理变化的影响。(2)选用Wistar大鼠,采用灌胃脂肪乳剂的方法建立大鼠高脂血症模型,分别用3g/kg、1.5g/kg剂量的维药芹菜根醇提物连续喂饲大鼠30天,取血清测定大鼠血清总胆固醇(CHO)、甘油三脂(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、超氧化物歧化酶(SOD)活性及丙二醛(MDA)含量。结果:(1)芹菜根醇提物能明显降低CCl4、D-GaIN引起的急性肝损伤动物血清ALT、AST水平,其高剂量能明显提高肝组织SOD活性,降低MDA含量。芹菜根醇提物能明显升高PAR引起的急性肝损伤动物肝组织SOD活性,降低MDA含量,其高剂量能明显降低动物血清ALT、AST水平。肝组织病理变化观察发现芹菜根醇提物能改善CCl4、D-GaIN、PAR所致肝组织的损伤程度。(2)芹菜根醇提物能明显降低高脂血症大鼠血清CHO、TG、LDL-C和MDA含量,增高HDL-C及SOD活性。结论:维药芹菜根醇提物对CCl4、D-GaIN、PAR引起的急性肝损伤有一定的保护作用,并可降低高脂血症大鼠的血脂水平。
Objective: To observe the effect of aqueous extract of alcohol of the roots of Apium graveolens L on the acute liver injury that induced by carbon tetrachloride (CCl4)、D-Galactasamine (D-GaIN) and paracetamol(PAR). And to observe the influence of aqueous extract of alcohol of the roots of Apium graveolens L on experimental hyperlipidemia of rats. Methods: (1)Experimental hepatitis animal models were established in wistar rats by an single intraperitoneal injection of CCl(41ml/kg)、D-GaIN(500mg/kg),and an single intraperitoneal injection of PAR(300mg/kg )in mice,respectively. Serum Alanine transferase(ALT), Aspartate tranfe- rase(AST), liver Super oxide dismutase (SOD), Malondialdehyde(MDA) were examined. Also histopathological changes in the liver tissue were observed. (2)Set up the rats hyperlipidemia model by ig lipid emulsion, rats that in treatment groups were continually given aqueous extract of alcohol of the roots of Apium graveolens L at dosages of 3g/kg、1.5g/kg separately for 30 days. The serum levels of CHO, TG ,HDL-C, LDL-C, SOD, and MDA of rat were examined after 30 days. Results: (1)Both dosages of aqueous extract of alcohol of the roots of Apium graveolens L significantly decreased serum ALT and AST elevation and the high-dosage increased the SOD activities while lowered MDA content significantly in the CCl4 and D-GaIN induced hepatitis model. Both dosages of aqueous extract of alcohol of the roots of Apium graveolens L increased the SOD activities while lowered MDA content significantly in the PAR induced hepatitis model. And the high-dosage significantly decreased serum ALT and AST elevation. It was concl- uded that the aqueous extract of alcohol of roots of Apium graveolens L possesses a significant hepatoprotection against the three kinds of chemical induced hepatitis. (2)The aqueous extract of alcohol of the roots of Apium graveolens L significantly decreased serum CHO,TG,LDL-C and MDA, increased HDL-C and SOD on experimental hyperlipidemia of rats. Conclusion: The aqueous extract of alcohol of the roots of Apium graveolens L has protective effects for acute liver injury in rats induced by CCl4、D-GalNand PAR. It could reduce the level of blood lipids on experimental hyperlipidemia of rats.
Objective: To observe the effect of aqueous extract of alcohol of the roots of Apium graveolens L on the acute liver injury that induced by carbon tetrachloride (CCl4)、D-Galactasamine (D-GaIN) and paracetamol(PAR). And to observe the influence of aqueous extract of alcohol of the roots of Apium graveolens L on experimental hyperlipidemia of rats. Methods: (1)Experimental hepatitis animal models were established in wistar rats by an single intraperitoneal injection of CCl(41ml/kg)、D-GaIN(500mg/kg),and an single intraperitoneal injection of PAR(300mg/kg )in mice,respectively. Serum Alanine transferase(ALT), Aspartate tranfe- rase(AST), liver Super oxide dismutase (SOD), Malondialdehyde(MDA) were examined. Also histopathological changes in the liver tissue were observed. (2)Set up the rats hyperlipidemia model by ig lipid emulsion, rats that in treatment groups were continually given aqueous extract of alcohol of the roots of Apium graveolens L at dosages of 3g/kg、1.5g/kg separately for 30 days. The serum levels of CHO, TG ,HDL-C, LDL-C, SOD, and MDA of rat were examined after 30 days. Results: (1)Both dosages of aqueous extract of alcohol of the roots of Apium graveolens L significantly decreased serum ALT and AST elevation and the high-dosage increased the SOD activities while lowered MDA content significantly in the CCl4 and D-GaIN induced hepatitis model. Both dosages of aqueous extract of alcohol of the roots of Apium graveolens L increased the SOD activities while lowered MDA content significantly in the PAR induced hepatitis model. And the high-dosage significantly decreased serum ALT and AST elevation. It was concl- uded that the aqueous extract of alcohol of roots of Apium graveolens L possesses a significant hepatoprotection against the three kinds of chemical induced hepatitis. (2)The aqueous extract of alcohol of the roots of Apium graveolens L significantly decreased serum CHO,TG,LDL-C and MDA, increased HDL-C and SOD on experimental hyperlipidemia of rats. Conclusion: The aqueous extract of alcohol of the roots of Apium graveolens L has protective effects for acute liver injury in rats induced by CCl4、D-GalNand PAR. It could reduce the level of blood lipids on experimental hyperlipidemia of rats.
引文
[1]刘宇,李东杰.肝病用药综述.黑龙江医药,2007,20(1):76～77
[2]娄海燕,王菊英.保肝降酶中药的研究进展.药理学进展,2004,9(1):93～101
[3]刘浩然.中药降脂活性成分药理作用研究概述.湖南中医药导报,2002,12 (12):742
[4]张铁军,陈常青.调节血脂中药现代研究与应用.中药现代研究与应用丛书, 2007,1(1):3
[5]曹浈.高脂血症的治疗护理进展.护理研究,2008,22(2):380～382
[6]沈吉云,燕忠生.丹参保肝抗肝纤维化药理作用及应用进展.中西医结合肝病杂志,1998,8(2):125
[7]蒋莉,李跃华,戚晓红,等.丹参对内毒性肝损伤的防护作用及其机制研究.中西医结合肝病杂志,1999,9(2):36
[8]苏玮,郭群.白芍的现代药理研究概况.中医药信息,1996,12(4):9
[9]陈爽,偾长恩,杨美娟,等.芍药甙防治大鼠肝细胞体外损伤形态学及生物化学研究.中西医结合肝病杂志,1997,7(4):217
[10]孙沛毅,李瑞琴,孙云,等.当归对实验性肝损伤小鼠的抗自由基损伤作用.中西医结合肝病杂志,1996,6(4):21
[11]黄自平,梁扩寰,阮幼冰,等.当归对四氯化碳所致肝损伤大鼠的抗肝纤维化作用.中国病毒生理学杂志,1996,12(2):152
[12]王良骏,杜新加.五味子在肝病中的运用.中西医结合肝病杂志,1997,7 (3):185
[13]卢贺起.紫草的实验研究.中国中医药信息,1998,5(1):20
[14]张萦秦,李小宇,华琦.调脂中药的研究进展.张家口医学院学报,2001,18 (2):109～110
[15]王笑梅.高脂血症中药治疗研究进展.中医药信息,1997,18(l):9～10
[16]李爱群.山楂的心血管药理作用.湖南中医杂志,l988,4(4):33
[17]寇丈蓉.血脂康基础与临床研究概述.中华内科杂志,1998,37(6):364～366
[18]黄兆胜,王宗胜,刘明平,等.昆布对实验性高脂血症大鼠脂质代谢的影响.中国海洋药物,1998,17(1):35～37
[19]乐崇熙,潭建华.维吾尔医药概况.中草药,1986,17(1):40～45
[20] BORSW,M ICHELC,S TETTM A,etal.Antioxidant effects of flavonoids[J]. Biofactors,1997,6(4):399～402
[21] VAN ACKER SA,TROMP MN,HAENEN GR,etal. Flavonoids as scavengers of nitric oxide radical[J].Biochem Biophys Res Commun,1995,214(3):755～759
[22] UBED AA,ESTEVE ML,ALCARAZ MJ,etal.Effects of flavonoids on cytochrome P450 from rat liver microsomes inhibition of enzyme activities and protection against peroxidative damage[J].Phytother Res,1995,9:416～420
[23] BROWN JE,RICE-EVANS CA.Luteolin-rich artichoke extract protects low density lipoprotein from oxidation in vitro[J].Free Radic Res,1998,29 (3):247～255
[24] RE R,PELLEGRIN IN,PROTEGGENTE A,etal.Antioxidant activity applying an improved ABTS radical cationde colorization assay[J]. Free Radic Biol Med,1999,26(10):1231～1237
[25]徐任生.天然产物化学[M].北京:科学出版社,1993:588
[26]林启寿.中草药成分化学[M].北京:科学出版社,1977:343～344
[27]徐叔云,陈修.药理实验方法学第三版.人民卫生出版社,2005(5):200
[28]李茂言,何利城.微孔草总油对大鼠实验性高脂血症的防治作用[J].中国中药杂志,1999,24(2):106～108
[29]马建林,毛焕元.自制脂肪乳剂灌胃在家兔高脂血症模型制作中的应用[J].同济医科大学学报,1999,28(5):409～411
[30]毛新民,张瑜.保心脑胶囊对高脂血症大鼠血脂的影响.新疆医科大学学报,2006,29(12):1140～1142
[31]姚光弼.肝脏损伤的机制.中华消化杂志,1998,18(4):235～238
[32]杨天健,魏怀玲,刘耕陶.16种药物对卡介苗加脂多糖引起小鼠免疫性肝损伤的作用.中国药理学报,1997,18(2):185～188
[33]郭鹞.人类疾病的动物模型.北京人民卫生出版社,1990:186
[34]倪鸿昌,李俊,金涌.大鼠实验性高脂血症和高脂血症性脂肪肝模型研究.中国药理学通报,2004,20(6):703
[35]冯利平,寿蓉蓉,孙永红.SD大鼠高脂血症造模方法.浙江中医学院学报,1999,23(2):16
[36]李萍,谢金鲜,林启云.民族药余甘子对D-半乳糖胺致小鼠肝损伤的影响[J].中国民族民间医药杂志,2003,62:161～164
[37]姜洁,窦昌贵,张玉彬.注射用鲨鱼肝再生因子对小鼠急性化学性肝损伤的影响[J].药物生物技术,2004,11(1):324
[38]张秀明,陈科力,李翰明.蛇葡萄根的抗肝降酶及抗自由基损伤作用[ J] .中国药师,1999,2(5):225
[39]陈银石.拉米呋啶联用丹参治疗慢性乙型肝炎肝纤维化的疗效观察[ J] .热带医学杂志,2003,3(2):207～209
[40]王艳林.枳俱子抗脂质过氧化作用的实验研究[ J] .中草药,1994,25(6): 306
[41]陈万宁,万德胜.HBV前S1抗原与乙肝e系统及HBV DNA之间相关性探讨[J].热带医学杂志,2005,5(3):346～347
[42]赵水平.血脂第3讲高脂血症的病因[J].中国临床医生,2003,31(11):15～17
[43] CampeauL. Percutaneous radialartery approach for coronary angiography[J]. Cather Cardiovasc Diang,1989,16:3～7
[44] HudeloC,MaillardL,Quilliet L,etal.Comparison of coronary angiography by the left radial and right femoral approach with French catheters[J].Arch Mal Coeur Vaiss,2000,93(7):813
[45] Britton RS,Bacon BR. Role of free radicals in liver diseases and hepatic fibrosis[J]. Hepatogastroentero logy,1994,41(4):343～348
[46]王迪生,高继君.赤芍甘草冲剂对D-半乳糖诱导肝损伤的保护作用.中国临床药理学与治疗学,2006,11(9):1026～1029
[47]刘彦双,朱淑霞,王永利.急性肝损伤模型的研究进展.河北医药, 2007,29(6):613～614
[48] Merrick BA,Bruno ME,Madenspacher JH,etal.Alterations in the rat serum proteome during liver injury from acetaminophen exposure.JP harmacol Exp Ther,2006,318:792～802
[49]王开发.陆明花粉的植物多醇研究.蜜蜂杂志,2006,1(9):5～6
[1]刘勇民.维吾尔药志下册.乌鲁木齐.新疆科技卫生出版社,1999,9:346
[2]庄乾竹.水芹旱芹貌似相近食疗作用大不同.药食同源,2006,5:26～27
[3]李振琼.药用蔬菜芹菜.家庭医药,2005,10:53～54
[4]刘咏松.芹菜的本草研究及功用.四川中医,2004,22(7):25～26
[5]《全国中草药汇编》编写组.全国中草药汇编(下).人民卫生出版社,1978:129
[6]黄正明.水芹退黄降酶疗效的实验研究.中国中药杂志,1989,(2):84
[7]黄正明.水芹注射液抗肝炎的药理研究.中国中药杂志,1991,(5):304
[8]黄正明,杨新波,曹文斌.水芹提取液预防CCl4对肝损害的作用.中国中药杂志,1990,(6):373
[9]姬广聚.水芹注射剂的抗实验性心律失常作用.中国中药杂志,1990,(7):45
[10]江苏新医学院.中药大辞典(上册).上海科学技术出版社,1986:1122
[11]李宗友译.旱芹水提取物对喂饲高脂饲料大鼠的脂质参数的影响.国外医学.中医中药分册,1995,(6):44
[12]于树仁.芹菜甲素与乙素的抗惊厥作用.药学学报,1984,7(8):566
[13]于树仁.芹菜甲素保护脑细胞的作用.药学学报,1988,8(9):656
[14]李静,张子贵,吴馥梅,等.芹菜提取液对中老年小鼠学习记忆的影响.中草药, 1996,(2):104
[15]历强,马建仓译.芹菜素的药理学研究进展.国外医学,2003,25(3):147
[16]胡庆国.超临界CO2萃取芹菜籽油的工艺研究.食品研究与开发,2004,24(2): 30
[17]张桂,畅天狮,刘俊果,等.从芹菜中提取黄酮类物质的研究.食品科学,2002,23(8):121
[18]刘世民.微波法提取芹菜中黄酮类物质的探讨.食品研究与开发,2005,25 (3):48
[19]赵进,尤婷婷.超声波提取芹菜总黄酮及鉴别.时珍国医国药,2007,18(6): 1454～1455
[20]王克勤,陈静萍.芹菜叶黄酮提取工艺条件优化研究.食品与机械,2007, 23(4):95～97
[21]蒋新龙.山芹菜叶黄酮的提取工艺研究.中国酿造,2007,11:37～39
[22]毕丽君,李慧.水芹中总黄酮类化合物最佳提取工艺的研究.食品科学,1999,12:35～36
[23]乌莉娅·沙依提,耿萍.维药芹菜籽总黄酮含量测定及提取工艺研究.时珍国医国药,2007,18(9):2102～2103
[24]周辉,卢向阳.芹菜化学成分及药理活性研究进展.氨基酸和生物资源,2006,28 (1):6～9
[25]张捷莉,王君,李铁纯,等.美国西芹菜籽挥发性成分的GC/MS分析[J].食品科学,2002,23(8):225～227
[26]张捷莉,张胜彪,王君,等.天津实心芹菜籽挥发油成分的GC/MS分析[J].鞍山师范学院学报,2003,5(4):58～60
[27]张捷莉,李铁纯,王君等.两中不同的芹菜籽油中脂肪酸的GU/MS分析[J].中国油脂,2004,29(6):70～71
[28]高金燕,陈红兵.芹菜中活性成分研究进展.中国食物与营养,2005(7):28
[29] Kitajima J,lshikawa T,Satoh M. Polar constituents of celery seed [J] Phytoche- mistry,2003,64(5):1003～1011
[30]吕金良,热比古丽·斯拉木.维药芹菜籽化学成分研究.中成药,2007, 29(3):406～407
[31]乌莉娅·沙依提.维药芹菜根化学成分的研究.新疆中医药,2008,26(1):33～35
[32]王迎军,赵淑萍,郑翠兰.芹菜治疗原发性高血压80例.中国民间疗法,2003,7: 57～58
[33] O Ceska,SK Chaudhary, PJ Warrington and MJ.Ashwood-Smith1 Photoactive furocoumarins in fruits of some umbellifers[J].Phytoc hemistry,1986,26 (1):165～169
[34] SK Garg,SR. Gupta. Sharma .Apiumetin—a new furanocoumarin from the seeds of Apium graveolens[J].Phytochemistry,1978,17(12):2135～2136
[35] SK Garg,SR Gupta.Coumarins from Apium graveolens seeds[J] . Phytoche mistr- y, 1979,18(9):1580～1581
[36] Anil Jain,Narain D,Sharma,etal.Coumarins from Apium graveolens seeds [J]. Planta Medica,1986,246(3):2464
[37] SK Garg,SR Gupta ,Apiumoside.A new furanoco umarin glucoside from the see- ds of Apium graveolens[J].Phytochemistry,1979,18 (10):1764～1765
[38]董丽花,范增民.不同品种芹菜不同部位微量元素含量研究.微量元素与健康研究,2004,6(3):26～27
[2]娄海燕,王菊英.保肝降酶中药的研究进展.药理学进展,2004,9(1):93～101
[3]刘浩然.中药降脂活性成分药理作用研究概述.湖南中医药导报,2002,12 (12):742
[4]张铁军,陈常青.调节血脂中药现代研究与应用.中药现代研究与应用丛书, 2007,1(1):3
[5]曹浈.高脂血症的治疗护理进展.护理研究,2008,22(2):380～382
[6]沈吉云,燕忠生.丹参保肝抗肝纤维化药理作用及应用进展.中西医结合肝病杂志,1998,8(2):125
[7]蒋莉,李跃华,戚晓红,等.丹参对内毒性肝损伤的防护作用及其机制研究.中西医结合肝病杂志,1999,9(2):36
[8]苏玮,郭群.白芍的现代药理研究概况.中医药信息,1996,12(4):9
[9]陈爽,偾长恩,杨美娟,等.芍药甙防治大鼠肝细胞体外损伤形态学及生物化学研究.中西医结合肝病杂志,1997,7(4):217
[10]孙沛毅,李瑞琴,孙云,等.当归对实验性肝损伤小鼠的抗自由基损伤作用.中西医结合肝病杂志,1996,6(4):21
[11]黄自平,梁扩寰,阮幼冰,等.当归对四氯化碳所致肝损伤大鼠的抗肝纤维化作用.中国病毒生理学杂志,1996,12(2):152
[12]王良骏,杜新加.五味子在肝病中的运用.中西医结合肝病杂志,1997,7 (3):185
[13]卢贺起.紫草的实验研究.中国中医药信息,1998,5(1):20
[14]张萦秦,李小宇,华琦.调脂中药的研究进展.张家口医学院学报,2001,18 (2):109～110
[15]王笑梅.高脂血症中药治疗研究进展.中医药信息,1997,18(l):9～10
[16]李爱群.山楂的心血管药理作用.湖南中医杂志,l988,4(4):33
[17]寇丈蓉.血脂康基础与临床研究概述.中华内科杂志,1998,37(6):364～366
[18]黄兆胜,王宗胜,刘明平,等.昆布对实验性高脂血症大鼠脂质代谢的影响.中国海洋药物,1998,17(1):35～37
[19]乐崇熙,潭建华.维吾尔医药概况.中草药,1986,17(1):40～45
[20] BORSW,M ICHELC,S TETTM A,etal.Antioxidant effects of flavonoids[J]. Biofactors,1997,6(4):399～402
[21] VAN ACKER SA,TROMP MN,HAENEN GR,etal. Flavonoids as scavengers of nitric oxide radical[J].Biochem Biophys Res Commun,1995,214(3):755～759
[22] UBED AA,ESTEVE ML,ALCARAZ MJ,etal.Effects of flavonoids on cytochrome P450 from rat liver microsomes inhibition of enzyme activities and protection against peroxidative damage[J].Phytother Res,1995,9:416～420
[23] BROWN JE,RICE-EVANS CA.Luteolin-rich artichoke extract protects low density lipoprotein from oxidation in vitro[J].Free Radic Res,1998,29 (3):247～255
[24] RE R,PELLEGRIN IN,PROTEGGENTE A,etal.Antioxidant activity applying an improved ABTS radical cationde colorization assay[J]. Free Radic Biol Med,1999,26(10):1231～1237
[25]徐任生.天然产物化学[M].北京:科学出版社,1993:588
[26]林启寿.中草药成分化学[M].北京:科学出版社,1977:343～344
[27]徐叔云,陈修.药理实验方法学第三版.人民卫生出版社,2005(5):200
[28]李茂言,何利城.微孔草总油对大鼠实验性高脂血症的防治作用[J].中国中药杂志,1999,24(2):106～108
[29]马建林,毛焕元.自制脂肪乳剂灌胃在家兔高脂血症模型制作中的应用[J].同济医科大学学报,1999,28(5):409～411
[30]毛新民,张瑜.保心脑胶囊对高脂血症大鼠血脂的影响.新疆医科大学学报,2006,29(12):1140～1142
[31]姚光弼.肝脏损伤的机制.中华消化杂志,1998,18(4):235～238
[32]杨天健,魏怀玲,刘耕陶.16种药物对卡介苗加脂多糖引起小鼠免疫性肝损伤的作用.中国药理学报,1997,18(2):185～188
[33]郭鹞.人类疾病的动物模型.北京人民卫生出版社,1990:186
[34]倪鸿昌,李俊,金涌.大鼠实验性高脂血症和高脂血症性脂肪肝模型研究.中国药理学通报,2004,20(6):703
[35]冯利平,寿蓉蓉,孙永红.SD大鼠高脂血症造模方法.浙江中医学院学报,1999,23(2):16
[36]李萍,谢金鲜,林启云.民族药余甘子对D-半乳糖胺致小鼠肝损伤的影响[J].中国民族民间医药杂志,2003,62:161～164
[37]姜洁,窦昌贵,张玉彬.注射用鲨鱼肝再生因子对小鼠急性化学性肝损伤的影响[J].药物生物技术,2004,11(1):324
[38]张秀明,陈科力,李翰明.蛇葡萄根的抗肝降酶及抗自由基损伤作用[ J] .中国药师,1999,2(5):225
[39]陈银石.拉米呋啶联用丹参治疗慢性乙型肝炎肝纤维化的疗效观察[ J] .热带医学杂志,2003,3(2):207～209
[40]王艳林.枳俱子抗脂质过氧化作用的实验研究[ J] .中草药,1994,25(6): 306
[41]陈万宁,万德胜.HBV前S1抗原与乙肝e系统及HBV DNA之间相关性探讨[J].热带医学杂志,2005,5(3):346～347
[42]赵水平.血脂第3讲高脂血症的病因[J].中国临床医生,2003,31(11):15～17
[43] CampeauL. Percutaneous radialartery approach for coronary angiography[J]. Cather Cardiovasc Diang,1989,16:3～7
[44] HudeloC,MaillardL,Quilliet L,etal.Comparison of coronary angiography by the left radial and right femoral approach with French catheters[J].Arch Mal Coeur Vaiss,2000,93(7):813
[45] Britton RS,Bacon BR. Role of free radicals in liver diseases and hepatic fibrosis[J]. Hepatogastroentero logy,1994,41(4):343～348
[46]王迪生,高继君.赤芍甘草冲剂对D-半乳糖诱导肝损伤的保护作用.中国临床药理学与治疗学,2006,11(9):1026～1029
[47]刘彦双,朱淑霞,王永利.急性肝损伤模型的研究进展.河北医药, 2007,29(6):613～614
[48] Merrick BA,Bruno ME,Madenspacher JH,etal.Alterations in the rat serum proteome during liver injury from acetaminophen exposure.JP harmacol Exp Ther,2006,318:792～802
[49]王开发.陆明花粉的植物多醇研究.蜜蜂杂志,2006,1(9):5～6
[1]刘勇民.维吾尔药志下册.乌鲁木齐.新疆科技卫生出版社,1999,9:346
[2]庄乾竹.水芹旱芹貌似相近食疗作用大不同.药食同源,2006,5:26～27
[3]李振琼.药用蔬菜芹菜.家庭医药,2005,10:53～54
[4]刘咏松.芹菜的本草研究及功用.四川中医,2004,22(7):25～26
[5]《全国中草药汇编》编写组.全国中草药汇编(下).人民卫生出版社,1978:129
[6]黄正明.水芹退黄降酶疗效的实验研究.中国中药杂志,1989,(2):84
[7]黄正明.水芹注射液抗肝炎的药理研究.中国中药杂志,1991,(5):304
[8]黄正明,杨新波,曹文斌.水芹提取液预防CCl4对肝损害的作用.中国中药杂志,1990,(6):373
[9]姬广聚.水芹注射剂的抗实验性心律失常作用.中国中药杂志,1990,(7):45
[10]江苏新医学院.中药大辞典(上册).上海科学技术出版社,1986:1122
[11]李宗友译.旱芹水提取物对喂饲高脂饲料大鼠的脂质参数的影响.国外医学.中医中药分册,1995,(6):44
[12]于树仁.芹菜甲素与乙素的抗惊厥作用.药学学报,1984,7(8):566
[13]于树仁.芹菜甲素保护脑细胞的作用.药学学报,1988,8(9):656
[14]李静,张子贵,吴馥梅,等.芹菜提取液对中老年小鼠学习记忆的影响.中草药, 1996,(2):104
[15]历强,马建仓译.芹菜素的药理学研究进展.国外医学,2003,25(3):147
[16]胡庆国.超临界CO2萃取芹菜籽油的工艺研究.食品研究与开发,2004,24(2): 30
[17]张桂,畅天狮,刘俊果,等.从芹菜中提取黄酮类物质的研究.食品科学,2002,23(8):121
[18]刘世民.微波法提取芹菜中黄酮类物质的探讨.食品研究与开发,2005,25 (3):48
[19]赵进,尤婷婷.超声波提取芹菜总黄酮及鉴别.时珍国医国药,2007,18(6): 1454～1455
[20]王克勤,陈静萍.芹菜叶黄酮提取工艺条件优化研究.食品与机械,2007, 23(4):95～97
[21]蒋新龙.山芹菜叶黄酮的提取工艺研究.中国酿造,2007,11:37～39
[22]毕丽君,李慧.水芹中总黄酮类化合物最佳提取工艺的研究.食品科学,1999,12:35～36
[23]乌莉娅·沙依提,耿萍.维药芹菜籽总黄酮含量测定及提取工艺研究.时珍国医国药,2007,18(9):2102～2103
[24]周辉,卢向阳.芹菜化学成分及药理活性研究进展.氨基酸和生物资源,2006,28 (1):6～9
[25]张捷莉,王君,李铁纯,等.美国西芹菜籽挥发性成分的GC/MS分析[J].食品科学,2002,23(8):225～227
[26]张捷莉,张胜彪,王君,等.天津实心芹菜籽挥发油成分的GC/MS分析[J].鞍山师范学院学报,2003,5(4):58～60
[27]张捷莉,李铁纯,王君等.两中不同的芹菜籽油中脂肪酸的GU/MS分析[J].中国油脂,2004,29(6):70～71
[28]高金燕,陈红兵.芹菜中活性成分研究进展.中国食物与营养,2005(7):28
[29] Kitajima J,lshikawa T,Satoh M. Polar constituents of celery seed [J] Phytoche- mistry,2003,64(5):1003～1011
[30]吕金良,热比古丽·斯拉木.维药芹菜籽化学成分研究.中成药,2007, 29(3):406～407
[31]乌莉娅·沙依提.维药芹菜根化学成分的研究.新疆中医药,2008,26(1):33～35
[32]王迎军,赵淑萍,郑翠兰.芹菜治疗原发性高血压80例.中国民间疗法,2003,7: 57～58
[33] O Ceska,SK Chaudhary, PJ Warrington and MJ.Ashwood-Smith1 Photoactive furocoumarins in fruits of some umbellifers[J].Phytoc hemistry,1986,26 (1):165～169
[34] SK Garg,SR. Gupta. Sharma .Apiumetin—a new furanocoumarin from the seeds of Apium graveolens[J].Phytochemistry,1978,17(12):2135～2136
[35] SK Garg,SR Gupta.Coumarins from Apium graveolens seeds[J] . Phytoche mistr- y, 1979,18(9):1580～1581
[36] Anil Jain,Narain D,Sharma,etal.Coumarins from Apium graveolens seeds [J]. Planta Medica,1986,246(3):2464
[37] SK Garg,SR Gupta ,Apiumoside.A new furanoco umarin glucoside from the see- ds of Apium graveolens[J].Phytochemistry,1979,18 (10):1764～1765
[38]董丽花,范增民.不同品种芹菜不同部位微量元素含量研究.微量元素与健康研究,2004,6(3):26～27